GHO Capital buys Caprion from Chicago Growth Partners
Caprion Biosciences Inc has been recapitalized and acquired by GHO Capital Partners, a European healthcare investment firm. No financial terms were released. The seller in the deal is Chicago Growth Partners, a U.S. private equity firm that led the buyout of Caprion in mid-2012. Montréal-based Caprion is a provider of immunology and proteomics analytical laboratory services to pharmaceutical and biotechnology companies. It said the new partnership with GHO will support further broadening of the company's customer base and expansion in Europe and elsewhere around the globe.
21 July 2016•4 mins read
